B2M and neoplasm: This study not only identified a cancer cell subtype tS2 closely associated with lung adenocarcinoma metastasis but also uncovered that the reprogramming of tumor-derived vascular endothelial cell subsets in lung adenocarcinoma patients impaired antigen presentation (including B2M) and the homing activity of immune cells (58).